Related Experiment Video
Updated: Aug 20, 2026
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
SMAC is expressed de novo in a subset of cervical cancer tumors
Magali Espinosa1, David Cantu, Carlos M Lopez
1Subdirección de Investigación Básica. Instituto Nacional de Cancerología, México, DF MEXICO. maggiec73@hotmail.com <maggiec73@hotmail.com>
Background:
Smac/Diablo is a recently identified protein that is released from mitochondria after apoptotic stimuli. It binds IAPs, allowing caspase activation and cell death. In view of its activity it might participate in carcinogenesis. In the present study, we analyzed Smac expression in a panel of cervical cancer patients.
Methods:
We performed semi quantitative RT-PCR on 41 cervical tumor and 6 normal tissue samples. The study included 8 stage I cases; 16 stage II; 17 stage III; and a control group of 6 samples of normal cervical squamous epithelial tissue.
Results:
Smac mRNA expression was below the detection limit in the normal cervical tissue samples. In contrast, 13 (31.7%) of the 41 cervical cancer biopsies showed detectable levels of this transcript. The samples expressing Smac were distributed equally among the stages (5 in stage I, 4 in stage II and 4 in stage III) with similar expression levels. We found no correlation between the presence of Smac mRNA and histology, menopause, WHO stage or disease status.
Conclusions:
Smac is expressed de novo in a subset of cervical cancer patients, reflecting a possible heterogeneity in the pathways leading to cervical cancer. There was no correlation with any clinical variable.
Insights
Smac/Diablo protein is newly expressed in some cervical cancers, indicating varied cancer development pathways. This protein
Area of Science:
- Cell biology
- Molecular oncology
- Cancer research
Background:
- Smac/Diablo protein is released from mitochondria during apoptosis.
- It facilitates caspase activation, promoting cell death.
- Its role in carcinogenesis suggests potential involvement in cancer development.
Purpose of the Study:
- To investigate Smac/Diablo protein expression in cervical cancer.
- To determine if Smac/Diablo expression correlates with clinical variables in cervical cancer patients.
Main Methods:
- Semi-quantitative RT-PCR was used to analyze Smac mRNA expression.
- The study included 41 cervical tumor samples and 6 normal tissue samples.
- Samples were categorized by stage (I, II, III) and histology.
Main Results:
- Smac mRNA was undetectable in normal cervical tissues.
- Detectable Smac mRNA was found in 31.7% of cervical cancer biopsies.
- Smac expression showed no correlation with histology, menopause, WHO stage, or disease status.
Conclusions:
- Smac is expressed de novo in a subset of cervical cancers.
- This suggests heterogeneity in cervical cancer development pathways.
- No correlation was found between Smac expression and clinical variables.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...